U.S. Healthtech Stock News

Microsoft (NasdaqGS:MSFT) signed a multi year, US$750 million Azure AI cloud deal with Perplexity, adding a new large scale customer to its AI infrastructure business. The company introduced its Maia 200 AI chip, described as its most advanced in house AI inference processor to date for Azure data centers. Both moves come as investors question how Microsoft will balance heavy AI capital spending with near term financial returns and cloud capacity constraints. For you as an investor, this...

Atlantic Union Bankshares (AUB) is back in focus after its latest earnings release, the Sandy Spring integration update, and an increased common dividend, a combination that has drawn fresh attention from income oriented bank investors. See our latest analysis for Atlantic Union Bankshares. Those earnings, dividend moves and Sandy Spring updates have come alongside a 19.43% 90 day share price return and a 32.90% five year total shareholder return, suggesting momentum has been building over...

Lazard (NYSE:LAZ) has appointed Tracy Farr as its new Chief Financial Officer. The leadership change is intended to support the firm's long term growth and operational efficiency plans. Farr brings extensive internal experience at Lazard to the CFO role. Lazard, traded on the NYSE under the ticker NYSE:LAZ, recently closed at $53.72. The stock has seen a 4.6% return over the past week and 10.6% over the past month, with a 62.1% return over five years. In that context, a CFO transition can...

With the business potentially at an important milestone, we thought we'd take a closer look at NEXGEL, Inc.'s...

Caterpillar (CAT) just turned in its FY 2025 scorecard with fourth quarter revenue of US$19.1b and basic EPS of US$5.15, alongside net income of US$2.4b. Over recent quarters, the company has seen revenue move from US$16.0b in Q3 2024 to US$17.6b in Q3 2025 and then US$19.1b in Q4 2025. Basic EPS shifted from US$5.09 to US$4.91 and then US$5.15 over the same stretch, setting up a results season where investors are weighing solid top line scale against a backdrop of compressed net margins and...

Central Securities (CET) has been in focus after reporting 9.3% year over year growth in net assets and higher net assets per share, alongside its stock touching an all time high of US$52.46. See our latest analysis for Central Securities. The latest share price of US$52.10 sits just below its recent all time high, and the 1 year total shareholder return of 15.44% and 5 year total shareholder return of 106.06% point to momentum that has built over time rather than fading quickly. If Central...

Readers hoping to buy Princeton Bancorp, Inc. ( NASDAQ:BPRN ) for its dividend will need to make their move shortly, as...

With a price-to-earnings (or "P/E") ratio of 38.8x Vitesse Energy, Inc. ( NYSE:VTS ) may be sending very bearish...

Oracle (NYSE:ORCL) is set to become a significant part-owner and technology partner of a new, majority American-owned TikTok U.S. joint venture. The company will act as managing investor and primary cloud provider for TikTok U.S., with a focus on data protection and AI infrastructure. Oracle has launched the Oracle Life Sciences AI Data Platform, aimed at applying generative AI to pharmaceutical and medical research. Recent cloud infrastructure partnerships, including arrangements with IHG...

If you are wondering whether BeOne Medicines is attractively priced right now, the key question is how its current share price stacks up against its underlying fundamentals. The stock has returned 0.3% over the last 7 days, 12.0% over 30 days, 9.4% year to date, 51.3% over 1 year and 32.5% over 3 years, while the 5 year return stands at an 8.5% decline. These moves sit against a backdrop of ongoing interest in the pharmaceuticals and biotech space, where investors often react quickly to...

If you are wondering whether Advanced Micro Devices shares are priced for perfection or still offer value, especially after their strong run, this article walks through what the numbers say about the stock. The share price recently closed at US$236.73, with a 1 year return of 104.2% and a 3 year return of 175.0%, even after a 7 day return of an 8.8% decline and a 30 day return of 10.5%. Recent headlines around Advanced Micro Devices have focused on its position in high performance chips and...

Asana’s recent performance in focus Asana (ASAN) has been drawing attention after a weak share price stretch, with the stock showing negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Asana. At a share price of $10.25, Asana’s recent 7 day share price return of a 7.99% decline and 30 day share price return of a 25.24% decline suggest fading momentum, which lines up with its 51.97% 1 year total shareholder return decline and...

Bristol-Myers Squibb, NYSE:BMY, has entered a collaboration with Janux Therapeutics to co-develop a tumor-activated cancer therapy targeting solid tumors. The company also announced an agreement with Microsoft to apply artificial intelligence to support earlier detection of lung cancer. Both partnerships focus on expanding Bristol-Myers Squibb's oncology capabilities in treatment and diagnostics. Bristol-Myers Squibb is trading at $55.05, with a 3.0% return year to date and a 10.2% return...

If you are wondering whether Olema Pharmaceuticals is still priced attractively after its recent run, this article walks through the numbers in a clear, valuation focused way. The stock recently closed at US$25.72, with returns of 1.9% over 7 days, 2.9% over 30 days, 1.7% year to date and 320.9% over the past year, while the 3 year return sits at 465.3% and the 5 year return at a 45.7% decline. Recent attention on Olema has centered on its position in the pharmaceuticals and biotech space...

Hut 8 Corp. has announced it will release its full-year 2025 results on February 25, 2026, alongside a conference call and webcast reviewing performance across its Bitcoin mining and data center operations in North America. The company’s shift toward AI infrastructure and high-performance computing marks a meaningful evolution of its business model beyond pure Bitcoin mining exposure. Next, we’ll examine how Hut 8’s move into AI-focused compute and data centers shapes its investment...

Key Insights Significant control over Cheetah Mobile by public companies implies that the general public has more power...

WisdomTree (WT) just posted its FY 2025 third quarter numbers, with total revenue of US$125.6 million and basic EPS of US$0.14, setting the tone with US$19.0 million in net income excluding extraordinary items. The company has seen quarterly revenue move from US$108.1 million in Q1 FY 2025 to US$112.6 million in Q2 and US$125.6 million in Q3. Basic EPS shifted from US$0.17 in Q1 and Q2 to US$0.14 in Q3, all against a trailing twelve month backdrop of US$457.0 million in revenue and EPS of...

Donaldson Company, Inc. announced that chief operating officer Richard Lewis will become president and chief executive officer and join the Board on March 2, 2026, succeeding long-serving leader Tod Carpenter, who will retire from those roles on March 1, 2026 and transition to executive chairman. The Board also declared a regular quarterly cash dividend of US$0.30 per share, extending Donaldson’s 70-year streak of uninterrupted quarterly payouts and marking the 30th consecutive year of...

If you are wondering whether S&P Global's share price still reflects good value after a long run in the market, you are not alone. The stock last closed at US$527.79, with a 1.1% decline over the past 7 days, a 1.0% return over 30 days, and returns of 3.0% year to date, 2.0% over 1 year, 45.1% over 3 years, and 69.8% over 5 years. Recent coverage around S&P Global has focused on its role as a major provider of financial data and credit ratings, and how investors view companies that supply...

If you are wondering whether Global Partners' share price still offers value after past gains and recent swings, starting with a clear look at its current valuation can help frame your next move. Over shorter periods the stock has had mixed returns, with 6.7% over the past week, 12.8% over the past month, 11.7% year to date, a 7.3% decline over the past year and a very large gain of about 2.4x over five years. Recent price moves sit against a backdrop of ongoing interest in energy...

Insiders who purchased Rani Therapeutics Holdings, Inc. ( NASDAQ:RANI ) shares in the past 12 months are unlikely to be...

TMC the metals (TMC) is back in focus after a sharp 17.7% share price drop, as investors weigh the U.S. government’s new equity stake in USA Rare Earth against TMC’s expanded deep sea mining permit application. See our latest analysis for TMC the metals. The recent 11.85% one day share price decline, and 29.87% 7 day share price return, sit against a 30 day share price return of 7.29% and a very large 1 year total shareholder return of about 4x. This suggests momentum has cooled as investors...

If you are wondering whether monday.com shares offer good value after a rough stretch, this article walks through what the current price might be telling you. The stock last closed at US$114.75, with returns of 11.3% decline over 7 days, 22.2% decline over 30 days, 20.0% decline year to date, and 55.1% decline over the past year, which may change how investors think about both upside and risk. Recent coverage has focused on monday.com as a prominent work management and collaboration...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...